Wymzya Fe
Product Images NDC 68180-899

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Wymzya Fe (NDC 68180-899). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Lupin Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Norethindrone Structural Formula (Wymzya Fe 1)

Chemical structure diagram of the active ingredient in WYMZYA FE by Lupin Pharmaceuticals, Inc. The structure shows a steroid backbone with a ketone (O=) group, a hydroxyl (OH) group, a methyl (CH3) group, and an acetylene (C≡CH) substituent.*

FDA Label Image

Ethinyl Estradiol Structural Formula (Wymzya Fe 2)

Chemical structure diagram showing a steroid-like molecule with hydroxyl groups and an alkyne substituent. The image does not show a label or text, but depicts the molecular framework characteristic of a corticosteroid or related compound.*

FDA Label Image

Figure 1 Circulatory Disease Mortality Rates Per 100,000 Women-years By Age, Smoking Status And Oral Contraceptive Use (Wymzya Fe 3)

A bar chart depicting circulatory disease mortality rates per 100,000 women-years segmented by age groups (15-24, 25-34, 35-44, 45+) and categorized by smoking status and oral contraceptive use. The chart compares ever-users (nonsmokers and smokers) with controls (nonsmokers and smokers). Mortality rates increase with age, notably higher for smokers who are ever-users of oral contraceptives in older age groups.*

FDA Label Image

Wymzya Dispenser Card (Wymzya Fe 4)

WYMZYA FE chewable tablets packaging label, showing a visual 28-day pill schedule arranged in 4 rows representing weeks 1 to 4. The active tablets are indicated for weeks 1 to 3, with week 4 tablets marked inactive. The label includes the proprietary name, active ingredients (norethindrone and ethinyl estradiol, ferrous fumarate), and dosage strength (0.4 mg/35 mcg). The manufacturer is Lupin Pharmaceuticals, Inc.*

FDA Label Image

Wymzya Credit Card Image (Wymzya Fe 5)

WYMZYA Fe chewable tablets packaging label with active ingredients norethindrone and ethinyl estradiol, plus ferrous fumarate tablets in 0.4 mg/35 mcg strength. The label shows a 4-week pill pack organized by day and week, with weeks 1 to 3 active and week 4 inactive. Manufactured by Lupin Pharmaceuticals, Inc.*

FDA Label Image

Lupin Logo (Wymzya Fe 6)

FDA Label Image

Ndc 68180-899-13 Wymzyatm Fe (norethindrone And Ethinyl Estradiol Tablets, Chewable And Ferrous Fumarate Tablets) 0.4 mg/35 Mcg 5 Blister Cards. Each Blister Card Contains 28 Tablets (Wymzya Fe 7)

Packaging label for WYMZYA FE chewable tablets, containing norethindrone and ethinyl estradiol with ferrous fumarate, 0.4 mg/35 mcg strength. The label indicates a 28-day regimen with 5 blister cards containing 28 tablets in total. The product is labeled by Lupin Pharmaceuticals, Inc. and includes storage instructions and a note that it is Rx only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.